Long Position on DYN @ $43.00 on 8/12/2024 (Fundamentals)

Dyne Therapeutics, Inc. (DYN), a clinical-stage muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States.

It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics.

Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.

Entry Point: $43.00

Trading Range: $39.23 - $140.76

Stop Loss: $40.85

Target Price: $47.30

Position closed on 8/28/2024 at price of $44.50 with a 3.49% gain in 16 days.

Back to Portfolio